Ebru Didem Kuran

Ebru Didem Kuran

Auto-generated profile, based on publicly available information

Ebru Didem Kuran

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Beyazıt, Istanbul 34116, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
FÇFurkan Çakır
Furkan Çakır
ŞAŞeyma Ateşoğlu
Şeyma Ateşoğlu
AKAytekin Köse
Aytekin Köse
MGMansour Ghaffari-Moghaddam
Mansour Ghaffari-Moghaddam
FAFahri Akbaş
Fahri Akbaş
HŞHalil ŞENOL
Halil ŞENOL

29 February 2024 in Phosphorus, Sulfur, and Silicon and the Related Elements
Verified
Journal Article
Closed access
EDEfe Doğukan Dincel
Efe Doğukan Dincel
EKEbru Didem Kuran
Ebru Didem Kuran
BOBeyza Onarer
Beyza Onarer
YFYusuf Fıstıkçı
Yusuf Fıstıkçı
IGİlhami Gülçin
İlhami Gülçin
NUNuray Ulusoy-Güzeldemirci
Nuray Ulusoy-Güzeldemirci


20 April 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
EKEbru Didem Kuran
Ebru Didem Kuran
EDEfe Doğukan Dincel
Efe Doğukan Dincel
SBSevde Nur Biltekin
Sevde Nur Biltekin
GAGülşen Akalın-Çiftçi
Gülşen Akalın-Çiftçi
NUNuray Ulusoy-Güzeldemirci
Nuray Ulusoy-Güzeldemirci

30 September 2024 in Archiv der Pharmazie
Verified
Journal Article
Closed access
EKEbru Didem Kuran
Ebru Didem Kuran
BUBurcu Uner
Burcu Uner
MCMuhammet Emin Cam
Muhammet Emin Cam
NUNuray Ulusoy‐Guzeldemirci
Nuray Ulusoy‐Guzeldemirci

5 September 2025 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
EDEfe Doğukan DİNCEL
Efe Doğukan DİNCEL
EKEbru Didem Kuran
Ebru Didem Kuran
HDHarika Öykü Dinç
Harika Öykü Dinç
FBFaika Başoğlu-Ünal
Faika Başoğlu-Ünal
EGEmrah Güler
Emrah Güler
NGNuray Ulusoy Güzeldemirci
Nuray Ulusoy Güzeldemirci
This study focused on synthesizing and characterizing novel thiosemicarbazide derivatives containing a 1,2,4-triazole moiety and evaluating their antimicrobial activity against several bacterial strains. The research aimed to identify key structural features that enhance antimicrobial efficacy through structure-activity relationship analysis and identify the minimum inhibitory concentration (MIC) of the most potent compounds to assess their potential for further development as antimicrobial agents. Nine novel thiosemicarbazide derivatives containing a 1,2,4-triazole moiety were synthesized by reacting 1,2,4-triazole derivatives with thiosemicarbazide precursors, and the products were characterized using infrared spectroscopy, proton nuclear magnetic resonance (1H-NMR), carbon-13 nuclear magnetic resonance (13C-NMR) spectroscopy, and elemental analysis. The antimicrobial activity of these compounds (5a-i) was tested against Klebsiella pneumoniae (K. pneumoniae),Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, and Pseudomonas aeruginosa (P. aeruginosa), using microdilution, disk diffusion, and broth microdilution methods. Dimethyl sulfoxide was used as a negative control, and Vancomycin and Meropenem were used as positive controls, with all results converted to µM for consistent analysis. The synthesized thiosemicarbazide derivatives (5a-i) were confirmed to be structurally correct through Fourier-transform infrared spectroscopy, 1H-NMR, and 13C-NMR spectroscopy. Among the tested compounds, 5e (4-bromophenyl) and 5g (n-propyl) showed significant antimicrobial activity, with 5g exhibiting the strongest effects against S. aureus and P. aeruginosa. Other derivatives, such as 5b (4-NO2Ph), 5c (4-FPh), and 5d (4-ClPh), showed moderate activity, while no significant activity was observed against K. pneumoniae or E. faecalis. The study successfully synthesized a series of novel thiosemicarbazide derivatives with a 1,2,4-triazole moiety and evaluated their antimicrobial potential. Compounds 5e and 5g exhibited significant antibacterial activity, particularly against S. aureus and P. aeruginosa, with MIC values in the low micromolar range. These findings suggest that the compounds hold promise as potential antimicrobial agents, and further studies should focus on optimizing their efficacy and exploring their mechanism of action.